demonstrated that silencing PD‐L1 in aggressive HCC cell lines significantly inhibited DNMT1 expression, accompanied by global DNA hypomethylation and dysregulation of the tumour stem cell marker EpCAM.255. This evidence concerns the gene CD274 and neoplasm.